Research And Development
Biotechnology
Biopharmaceutical
BioCryst
$3.359876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.35
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-1.18%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell BioCryst and other stocks, options, ETFs, and crypto commission-free!
About BCRX
BioCryst Pharmaceuticals, Inc. designs, optimizes and develops novel small molecule drugs that block key enzymes involved in the pathogenesis of diseases. Its drug candidates include rapivab, alpivab, rapiacta, peramiflu, BCX7353, BCX9930, BCX9250, Galidesivir, and Mundesine. Read More The company was founded in 1986 and is headquartered in Durham, NC.
Employees
100
Headquarters
Durham, North Carolina
Founded
1986
Market Cap
373.82M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
1.19M
High Today
$3.41
Low Today
$3.29
Open Price
$3.39
Volume
871.77K
52 Week High
$9.95
52 Week Low
$2.80
Collections
Research And Development
Biotechnology
Biopharmaceutical
Pharmaceutical
Health
Technology
US
North America
Price Paid on Robinhood
15% Lower
Right Now
52 Week Low
$2.80
Average Price Paid
$3.96
52 Week High
$9.95
Analyst Ratings
67%
of 9 ratings
Buy
67%
Hold
33%
Sell
0%
BCRX Earnings
-$0.28
-$0.24
-$0.19
-$0.15
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Aug 6, Pre-Market